Coordinators: Stéphanie Blandin and Nicolas Blanchard
Participants: Blandin, Delauw, Blanchard, Pied, Mazier, Silvie, Scherf /Mecheri
We will examine mechanisms of protective immunity employed by vectors and hosts against protozoan parasites. On the vector side, we will focus on the innate arm of the immune responses and will dissect mechanisms of complement-like cascade activation and Plasmodium killing in the African malaria vector Anopheles gambiae. In the mammalian host, we have chosen to examine how modulation of CD8 responses by spatial and temporal compartmentalization of parasite antigens impacts resistance of a mammalian host to Toxoplasma gondii and to the liver stages of P. berghei. This WP will contribute to a better understanding of the mechanisms of immunity and may reveal novel strategies to rationalize vaccine design.
Mechanisms of anti-parasite immunity
This WP aims at identifying the mechanisms of protective immunity employed by vectors and hosts against protozoan parasites.
Description of work: We will dissect the innate immune mechanisms that mediate Plasmodium killing in the African malaria vector Anopheles gambiae. One of the key players that determine mosquito resistance to malaria parasites is the complement-like protein TEP1. Our aim is to decipher the molecular mechanisms that underlie the unique proprieties of TEP1 and of its interacting partners in killing malaria parasites and bacteria. For this purpose, we will develop and use a simple and robust functional screen to analyze the contribution of candidate TEP1interacting proteins to mosquito resistance to malaria. In the mammalian host, protozoan parasites secrete many effectors in the parasitophorous vacuole, some of which reach the MHC I presentation pathway and are targeted by CD8+ T cell responses with various efficacies and different protective outcomes. We will examine how modulation of CD8+ T cell responses by spatial and temporal compartmentalization of parasite antigens impacts host resistance to Toxoplasma gondii or liver stages of Plasmodium. Comparative analysis of the two infection systems should identify conserved mechanisms underlying parasite evasion strategies and host susceptibility to malaria and toxoplasmosis. This WP will contribute to a better understanding of the mechanisms of immunity and may reveal novel strategies to rationalize vaccine design.
Deliverables:
D1. Demonstration of protein networks underlying anti-parasitic responses in mosquitoes (Blandin/Levashina)
D2. Impact of spatial and temporal compartmentalization on antigen presentation and parasite control during Toxoplasma infection and malaria pre-erythrocytic stages (Blanchard, Delauw, Silvie)
Mechanisms of pathogenesis.
In this WP we will investigate the mechanisms involved in the pathogenesis of parasitic diseases including
severe forms of malaria and trypanosomiasis, in animal models and humans. Description of work: Cerebral malaria (CM), one of the most severe complications of malaria, is characterized by the sequestration of parasitized erythrocytes and leukocytes in brain capillaries. Experimental rodent models of CM have suggested that CD8+ T cells and neutrophil-associated high affinity receptor for IgE may contribute to the pathogenesis of CM. Parasite-derived epitopes recognized by CD8+ T cells in susceptible mice are unknown. Using an expression cloning approach in an established experimental model for CM (P. berghei ANKA strain in susceptible mice), we will identify parasite antigens recognized by CD8+ T cells during CM and use that knowledge to advance our understanding of the mechanisms of CM pathogenesis. Furthermore, we will analyse the molecular and cellular components that modulate the expression of FceRI on neutrophils during infection and characterize the mechanisms leading to FceRI-positive neutrophil adhesion to the brain vasculature. Severe malaria is prevalent in Eastern India, where clinical and ethnic signatures are different from the widely studied African population. To identify immune signatures associated with P. falciparum malaria protection or severity, we will analyze genome-wide host associations linked to clinical investigations and immune responses studies using transcriptomic, genomic and proteomic approaches performed on well-characterized groups of malaria patients in India. By providing a global integrated multidimensional view of malaria, we will generate information that may be useful for the design of new control strategies against malaria and possibly other mosquito-borne infections. We will also investigate parasite factors involved in the pathogenesis of severe malaria. Through transcriptomic analysis of P. falciparum field isolates, we have previously defined a set of candidate parasite genes associated with severe P. falciparum malaria. We will study the role of these molecules during CM using established in vitro assays of endothelial cell damage, and a novel humanized mouse model specifically designed for in vivo analysis of P. falciparum pathogenesis.
Anaemia is the main pathological feature of African Animal Trypanosomiasis (AAT). Variations in erythrocyte sialylation states have been described in AAT and recent studies on T. congolense and T. vivax, the most virulent species causing AAT, proposed that trypanosomal sialidases contribute to erythrocyte surface desialylation, thereby inducing erythrophagocytosis and subsequent anaemia. Using a novel ex vivo erythrophagocytosis model combined with genetic approaches, we will investigate the role of parasite sialidases in anaemia and screen for additional trypanosomal molecules that contribute to anaemia.
Deliverables
D1: Antigen specificity and effector profile of sequestered CD8+ T cells during CM (Blanchard)
D2: Validated database which associates human immune responses (antibody, T cells and cytokines) with different malaria clinical sub phenotypes in India (Pied and Indian collaborators)
D3: Identification of P. falciparum molecules implicated in cerebral malaria pathogenesis (Mazier, Mecheri/Scherf)
D4: Identification of parasite effectors of erythrophagocytosis during African Animal Trypanosomiasis
(Baltz)
Postdoctoral position, Institut Pasteur, Paris, France A 24-month post-doctoral position starting on March 1st 2025 and funded by the French National Research Agency (ANR) is available in the Trypanosome...
Postdoctoral positions, LPHI Lab, Montpellier, France Two ERC-funded (JANUS 2024-2029) postdoc positions are open in the lab to study cell cycle regulation in malaria...
Postdoctoral position, Institut Pasteur, Paris, France A postdoc position is available at the Institut Pasteur Paris, in the signalling and host-parasite interactions research group, headed by Dr Najma Rachidi...
ABOUT SPEAKERS PROGRAMME REGISTRATION CONTACT LOCATION About the workshop ParaFrap is organizing the ParaFrap Next Generation in Parasitology...
[Communiqué] As part of the actions of the Health Innovation Plan 2030, the health component of the France 2030 plan, Mohamed-Ali Hakimi is one of the 22 laureates of an Excellence Chair in Biology/Health, supported to conduct high-level research...
The York Biomedical Research Institute (YBRI) are hosting an online live seminar on Friday 24th May 1-2pm BST as part of their biomedical science seminar series. You are all welcome to attend - registration is required via the...
[Communiqué] Congratulations to Arthur Talman, IRD Research Leader in the MIVEGEC laboratory (Montpellier), who has been awarded an Advanced Grant from the European Research Council (ERC) for the project "TROJAN - Molecular mimicry and immune...
Ana Rita Gomes, a CNRS Research Associate at the Laboratory of Pathogens and Host Immunity in Montpellier, and former Postdoctoral fellow of the LabEx ParaFrap, has been awarded the prestigious CNRS Bronze Medal in 2023. This...
Happy New Year 2024! To kick off this new scientific year, here is the ParaFrap webinar schedule. Since January 2021, ParaFrap has been organizing a series of webinars. This monthly event, held every 2nd Thursday of the month, aims to strengthen...
The team of Dr. Mohamed-Ali Hakimi, in collaboration with Isabelle Coppens (Johns Hopkins University Bloomberg School of Public Health and Malaria Research Institute, Baltimore, MD, USA), has developed a new (epi)genetic method to produce in vitro...
© 2023. All rights reserved MLCOM
Notre site LabEx ParaFrap utilise des cookies pour réaliser des statistiques de visites, partager des contenus sur les réseaux sociaux et améliorer votre expérience. En refusant les cookies, certains services seront amenés à ne pas fonctionner correctement. Nous conservons votre choix pendant 30 jours. Vous pouvez changer d'avis en cliquant sur le bouton 'Cookies' en bas à gauche de chaque page de notre site. En savoir plus
Ce site utilise des cookies pour assurer son bon fonctionnement et ne peuvent pas être désactivés de nos systèmes. Nous ne les utilisons pas à des fins publicitaires. Si ces cookies sont bloqués, certaines parties du site ne pourront pas fonctionner.
Ce site utilise des cookies de mesure et d’analyse d’audience, tels que Google Analytics et Google Ads, afin d’évaluer et d’améliorer notre site internet.
Ce site utilise des composants tiers, tels que NotAllowedScript674ff4f1839d0ReCAPTCHA, Google NotAllowedScript674ff4f183337Maps, MailChimp ou Calameo, qui peuvent déposer des cookies sur votre machine. Si vous décider de bloquer un composant, le contenu ne s’affichera pas
Des plug-ins de réseaux sociaux et de vidéos, qui exploitent des cookies, sont présents sur ce site web. Ils permettent d’améliorer la convivialité et la promotion du site grâce à différentes interactions sociales.
Ce site web utilise un certain nombre de cookies pour gérer, par exemple, les sessions utilisateurs.